Eiger BioPharmaceuticals, Inc.
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Sri Ryali:
    00
  • David Cory:
    02
  • Ingrid Choong:
    09
  • Eldon Mayer:
    16
  • Sri Ryali:
    21
  • David Cory:
    23
  • Operator:
    24
  • Maury Raycroft:
    25
  • David Cory:
    25
  • Ingrid Choong:
    25
  • David Cory:
    26
  • Maury Raycroft:
    26
  • David Cory:
    26
  • Maury Raycroft:
    28
  • David Cory:
    28
  • Operator:
    28
  • Yigal Nochomovitz:
    28
  • David Cory:
    28
  • Ingrid Choong:
    28
  • David Cory:
    29
  • Yigal Nochomovitz:
    30
  • David Cory:
    31
  • Ingrid Choong:
    32
  • David Cory:
    33
  • Eldon Mayer:
    33
  • Yigal Nochomovitz:
    34
  • David Cory:
    34
  • Yigal Nochomovitz:
    35
  • Operator:
    35
  • Brian Skorney:
    35
  • David Cory:
    36
  • Eldon Mayer:
    36
  • David Cory:
    37
  • Brian Skorney:
    38
  • David Cory:
    38
  • Operator:
    38
  • Bert Hazlett:
    38
  • David Cory:
    39
  • Ingrid Choong:
    39
  • David Cory:
    39
  • Bert Hazlett:
    40
  • Sri Ryali:
    40
  • Bert Hazlett:
    41
  • Sri Ryali:
    41
  • Operator:
    41
  • Farhana Sakloth:
    41
  • David Cory:
    41
  • Eldon Mayer:
    42
  • David Cory:
    42
  • Farhana Sakloth:
    44
  • Sri Ryali:
    44
  • Farhana Sakloth:
    44
  • David Cory:
    44
  • Operator:
    44
  • Sri Ryali:
    44
  • Operator:
    45

Other Eiger BioPharmaceuticals, Inc. earnings call transcripts: